Modified 4'-nucleosides as antiviral agents

Details Modified 4'-nucleosides as antiviral agents Modified 4'-nucleosides as antiviral agents

C - Chemistry, Metallurgy

12

P

C12P 19/38 (2006.01) C12P 19/30 (2006.01) C12P 19/40 (2006.01)

Patent

CA 2623522

Compounds, methods and compositions for treating a host infected with human immunodeficiency virus and hepatitis B virus comprising administering an effective amount of a described 4'-C-substituted /3-D- and /3-L-nucleoside or a pharmaceutically acceptable salt or prodrug thereof, are provided.

L'invention porte sur des composés, sur des méthodes et sur des compositions de traitement d'un hôte infecté par le virus de l'immunodéficience humaine et le virus de l'hépatite B, ces méthodes consistant à administrer une quantité effective d'un 4'-C-substitué ß-D et ß-L-nucléoside de l'invention ou d'un sel acceptable d'un point de vue pharmaceutique ou d'un promédicament de celui-ci.

Affiliated with

Also associated with

Rating

Modified 4'-nucleosides as antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified 4'-nucleosides as antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified 4'-nucleosides as antiviral agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1581013